Fluticasone furoate is a long-acting inhaled corticosteroid used for the daily maintenance treatment of asthma. It works by reducing inflammation in the airways, helping to prevent symptoms such as wheezing, coughing, and shortness of breath. Its prolonged duration of action allows for once-daily dosing, which can improve adherence compared to medications that require twice-daily use. Fluticasone furoate is often combined with a long-acting beta agonist like vilanterol (as in Breo Ellipta) for patients with moderate to severe asthma. It is generally well-tolerated and effective at reducing exacerbations when used regularly.